Primary |
Cervix Carcinoma |
71.4% |
Gastric Cancer |
28.6% |
|
Enterocolitis |
50.0% |
Intestinal Perforation |
33.3% |
Vascular Injury |
16.7% |
|
Secondary |
Hiv Infection |
21.0% |
Testis Cancer |
11.4% |
Bone Sarcoma |
7.3% |
Oesophageal Carcinoma |
5.6% |
Cervix Carcinoma |
5.4% |
Gastric Cancer |
5.2% |
Pineal Gland Cyst |
5.2% |
Chemotherapy |
4.5% |
Uterine Cancer |
4.3% |
Testicular Choriocarcinoma Stage Iii |
3.9% |
Testicular Neoplasm |
3.6% |
Pineal Neoplasm |
3.4% |
Small Cell Lung Cancer Stage Unspecified |
3.4% |
Prophylaxis Of Nausea And Vomiting |
2.8% |
Prophylaxis |
2.4% |
Gastric Ulcer |
2.1% |
Germ Cell Cancer |
2.1% |
Hyperlipidaemia |
2.1% |
Hyperuricaemia |
2.1% |
Hypothyroidism |
2.1% |
|
Interstitial Lung Disease |
10.0% |
Ventricular Tachycardia |
10.0% |
White Blood Cell Count Decreased |
9.0% |
Renal Impairment |
8.0% |
Pancreatitis Acute |
6.0% |
Respiratory Failure |
6.0% |
Deep Vein Thrombosis |
5.0% |
Pulmonary Fibrosis |
5.0% |
Stomatitis |
5.0% |
Liver Disorder |
4.0% |
Pancreatitis |
4.0% |
Pharyngeal Stenosis |
4.0% |
Renal Failure |
4.0% |
Azoospermia |
3.0% |
Bone Marrow Failure |
3.0% |
Leiomyosarcoma |
3.0% |
Palmar-plantar Erythrodysaesthesia Syndrome |
3.0% |
Shock |
3.0% |
Ventricular Fibrillation |
3.0% |
Acute Respiratory Failure |
2.0% |
|
Concomitant |
Idiopathic Thrombocytopenic Purpura |
22.8% |
Immune Thrombocytopenic Purpura |
17.3% |
Prophylaxis |
8.4% |
Viith Nerve Paralysis |
7.6% |
Pleural Mesothelioma Malignant |
6.0% |
Malignant Mediastinal Neoplasm |
4.3% |
Gastric Cancer |
3.5% |
Cancer Pain |
3.3% |
Polyuria |
3.0% |
Lung Adenocarcinoma Stage Iv |
2.7% |
Premedication |
2.4% |
Analgesic Therapy |
2.2% |
Constipation |
2.2% |
Cough |
2.2% |
Diabetes Mellitus |
2.2% |
Infection Prophylaxis |
2.2% |
Malignant Neoplasm Of Renal Pelvis |
2.2% |
Metastatic Renal Cell Carcinoma |
2.2% |
Uterine Cancer |
1.9% |
Gastric Cancer Recurrent |
1.6% |
|
Neuroblastoma |
13.1% |
Pulmonary Embolism |
8.2% |
Renal Impairment |
8.2% |
White Blood Cell Count Decreased |
8.2% |
Pancytopenia |
6.6% |
Liver Disorder |
4.9% |
Platelet Count Increased |
4.9% |
Renal Failure |
4.9% |
Shock |
4.9% |
Hyponatraemia |
3.3% |
Inappropriate Antidiuretic Hormone Secretion |
3.3% |
Lung Neoplasm Malignant |
3.3% |
Malignant Neoplasm Progression |
3.3% |
Neoplasm Recurrence |
3.3% |
Oculomucocutaneous Syndrome |
3.3% |
Oedema Peripheral |
3.3% |
Pancreatitis Acute |
3.3% |
Platelet Count Decreased |
3.3% |
Pneumonia |
3.3% |
Pyrexia |
3.3% |
|